digital health startups weight loss glp-1 research2guidance GLP-1 Weight Loss Drugs Used
Description
Abstract The glucagon-like peptide-1 (GLP-1) receptor is a validated drug target for metabolic disorders
Maintaining adequate B12 levels keeps homocysteine in the normal range, supporting the cardiovascular benefit tirzepatide already provides through its primary mechanism
doi: 10.1016/j.diabres.2015.12.003
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes (ATTAIN-2)
The result was a significant reduction in GLP-1 production, decreased insulin secretion, and elevated postprandial blood glucose
The psychological component matters as well
